LR, Y., Z, C., I, M., JR, D., S, K., JY, W., . . . VK, T. (2018). Immune response proteins as predictive biomarkers of doxorubicin-induced cardiotoxicity in breast cancer patients. Experimental biology and medicine (Maywood, N.J.), 243(3), 248. https://doi.org/10.1177/1535370217746383
Chicago Style (17th ed.) CitationLR, Yu, et al. "Immune Response Proteins as Predictive Biomarkers of Doxorubicin-induced Cardiotoxicity in Breast Cancer Patients." Experimental Biology and Medicine (Maywood, N.J.) 243, no. 3 (2018): 248. https://doi.org/10.1177/1535370217746383.
MLA (9th ed.) CitationLR, Yu, et al. "Immune Response Proteins as Predictive Biomarkers of Doxorubicin-induced Cardiotoxicity in Breast Cancer Patients." Experimental Biology and Medicine (Maywood, N.J.), vol. 243, no. 3, 2018, p. 248, https://doi.org/10.1177/1535370217746383.